Sector: Health Care
Director information for MANNKIND CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| ANTHONY HOOPER | Director | 71 | ["Director of BeOne Medicines, Ltd.","Executive vice president of Global Commercial Operations for Amgen Inc.","Senior Vice President, Global Commercial Operations at BMS","Assistant Vice President of Global Marketing for Wyeth Laboratories","Led the international marketing group for Lederle International","Law and MBA degrees from the University of South Africa"] | ["Compensation Committee","Audit Committee"] | 2026 |
| Christine Mundkur | Director | 57 | ["Chair of the board and chief executive officer at a pharmaceutical company developing inhaled drugs","Former Chief Executive Officer and non-voting Chairman of the Board of Directors for Impopharma Inc.","Led the transition of Impopharma from a clinical research organization to a generic pharmaceutical company","Former President and Chief Executive Officer of the U.S. Division and Head of Commercial Operations for North America for Sandoz, Inc.","Former Chief Executive Officer of Barr Laboratories, Inc.","Strategic consultant advising on global pharmaceutical business strategies","Board member of Cardinal Health","Former board member of Lupin Limited"] | ["Audit Committee","Nominating and Corporate Governance Committee"] | 2026 |
| James S. Shannon, M.D., MRCP (UK) | Chair of the Board of Directors | 69 | ["Extensive experience in drug development","Business acumen and judgment","Former Chief Medical Officer of GSK plc","Global Head of Pharma Development at Novartis AG","Senior Vice-President, Clinical Development at Sterling Winthrop Inc."] | ["Compensation Committee"] | 2026 |
| JENNIFER GRANCIO | Director | 54 | ["Global Head of Distribution at the TCW Group","Chief Executive Officer of Engine No. 1","Consulted through Grancio Capital","Founder and executive with BlackRock’s iShares business","Senior associate with PricewaterhouseCoopers","Board member for Ethic Inc.","Bachelor’s degree in economics and international relations from Stanford University","MBA degree in strategy and finance from Columbia Business School"] | ["Nominating and Corporate Governance Committee","Audit Committee"] | 2026 |
| MICHAEL A. FRIEDMAN, M.D. | Director | 82 | ["Business experience as an executive officer at biopharmaceutical companies","Experience at a leading clinical and research center specializing in cancer and diabetes","Service at the Food and Drug Administration","Presidency and CEO of the City of Hope National Medical Center","Senior Vice President of Research and Development for Pharmacia Corporation","Deputy Commissioner for Operations for the Food and Drug Administration","Bachelor of Arts degree from Tulane University","Doctorate in medicine from the University of Texas, Southwestern Medical School"] | ["Member, Nominating and Corporate Governance Committee"] | 2026 |
| Michael E. Castagna, Pharm.D. | Chief Executive Officer and Director | 49 | ["Extensive experience with commercial pharmaceutical companies","Former Chief Commercial Officer","Vice President at Amgen, Inc.","Executive Director at Bristol-Myers Squibb Company","Held positions with commercial responsibilities at Sandoz, EMD (Merck) Serono, Pharmasset, and DuPont Pharmaceuticals"] | [] | 2026 |
| RONALD J. CONSIGLIO | Director | 82 | ["Knowledge and understanding of accounting and finance","Experience as a board member and executive officer at financial services firms","Managing Director of Synergy Trading","Executive Vice President and Chief Financial Officer of Trading Edge, Inc.","Chief Executive Officer of Angeles Mortgage Investment Trust","Senior Vice President and Chief Financial Officer of Cantor Fitzgerald & Co.","Certified public accountant for over 17 years","Bachelor’s degree in accounting from California State University at Northridge"] | ["Chair, Audit Committee","Member, Nominating and Corporate Governance Committee"] | 2026 |
| SABRINA KAY, ED.D. | Director | 63 | ["CEO of Fremont Private Investments","Led operations and exits of several companies","Board member of East West Bank and Hagerty","Philanthropist with service on more than 30 charitable and civic boards","Ed.D. and M.Sc. degrees in education from the University of Pennsylvania","MBA from the University of Southern California"] | ["Audit Committee","Compensation Committee"] | 2026 |
| STEVE B. BINDER | Director | 63 | ["Knowledge and understanding of accounting and finance","Experience as a former executive officer at MannKind and Stryker Corporation","Senior leadership roles at BMS","Business acumen and judgment","Certified Public Accountant","B.S. degree in Accounting and Business Administration from Muhlenberg College"] | [] | 2026 |
